ProSomnus, Inc. (OSAPQ)
OTCMKTS: OSAPQ · Delayed Price · USD
0.0050
-0.0018 (-26.47%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Company Description
ProSomnus, Inc. operates as a medical technology company that develops, manufactures, and markets precision intraoral medical devices for treating and managing patients with obstructive sleep apnea.
The company sells its products to sleep dentists, sleep physicians, primary care providers, otolaryngologists, and other integrated healthcare service providers through a direct sales force.
ProSomnus, Inc. is headquartered in Pleasanton, California. On May 7, 2024, ProSomnus, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
ProSomnus, Inc.
Country | Canada |
Founded | 2016 |
Industry | Medical Devices |
Sector | Healthcare |
Employees | 136 |
Contact Details
Address: 5675 Gibraltar Dr Pleasanton, California 94588 United States | |
Phone | 844-537-5337 |
Stock Details
Ticker Symbol | OSAPQ |
Exchange | OTCMKTS |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001934064 |
Employer ID | 88-2978216 |
SIC Code | 3841 |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Jun 27, 2024 | 8-K | Current Report |
Jun 6, 2024 | 8-K | Current Report |
May 20, 2024 | 10-Q | Quarterly Report |
May 16, 2024 | 8-K | Current Report |
May 15, 2024 | NT 10-Q | Notification of inability to timely file Form 10-Q or 10-QSB |
May 8, 2024 | 8-K | Current Report |
Apr 30, 2024 | 8-K | Current Report |
Apr 29, 2024 | 10-K/A | [Amend] Annual report |
Apr 25, 2024 | 25-NSE | Filing |
Apr 19, 2024 | 8-K | Current Report |